Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Sibel Durak"'
Autor:
Hande Kaymakcalan, İlyas Kaya, Nagihan Cevher Binici, Emrah Nikerel, Burcu Özbaran, Mehmet Görkem Aksoy, Seda Erbilgin, Gonca Özyurt, Noor Jahan, Didem Çelik, Kanay Yararbaş, Leyla Yalçınkaya, Sezen Köse, Sibel Durak, Adife Gulhan Ercan‐Sencicek
Publikováno v:
Molecular Genetics & Genomic Medicine, Vol 9, Iss 8, Pp n/a-n/a (2021)
Abstract Background Phosphatase and tensin homolog (PTEN) germline mutations are associated with cancer syndromes (PTEN hamartoma tumor syndrome; PHTS) and in pediatric patients with autism spectrum disorder (ASD) and macrocephaly. The exact prevalen
Externí odkaz:
https://doaj.org/article/723c7d13b4c54af78267e57826ff1ebd
Publikováno v:
Pediatric Practice and Research. 10:123-130
Aim: While many countries around the world have faced similar challenges in pediatric palliative care as COVID-19, there have also been challenges that vary from country to country. In this study, it was aimed to evaluate the difficulties and opinion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4a46e2335a8e5c619b92dc6a0134cc6
https://doi.org/10.21765/pprjournal.1192793
https://doi.org/10.21765/pprjournal.1192793
Autor:
AslihanEsra Yuksel, Akin Tahillioglu, Sibel Durak, SeydaCeylan Ari, KazimKoray Ozgul, EyupSabri Ercan
Publikováno v:
Nigerian Journal of Clinical Practice; Vol. 25 No. 9 (2022); 1435-1444
Background: Healthcare professionals are exposed to the stress of the pandemic in the highest level and try to cope with the long‑term psychological consequences. Aim: This study mainly aimed to compare the anxiety and depression levels of resident
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4345aec1995b902a21f258c7ce35e5bc
https://pubmed.ncbi.nlm.nih.gov/36149202
https://pubmed.ncbi.nlm.nih.gov/36149202
Autor:
Ülkü, Akyol Ardıç, Eyüp Sabri, Ercan, Duygu, Aygüneş, Deniz, Yüce, Sibel, Durak, Buket, Kosova
Publikováno v:
Turk psikiyatri dergisi = Turkish journal of psychiatry. 28(2)
Methylphenidate is the first-choice medication for the Pervasive Developmental Disorders (PDDs), and comorbid Attention Deficit Hyperactivity Disorder (ADHD). But this approach generally results with poor outcomes, and increased adverse effects. It i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::63aaf3e2dacd7880055235d2923182c0
https://pubmed.ncbi.nlm.nih.gov/29192941
https://pubmed.ncbi.nlm.nih.gov/29192941
Publikováno v:
Journal of Child and Adolescent Psychopharmacology. 25:580-584
Obsessive-compulsive disorder (OCD) is a relatively frequent disease in childhood, which is generally treated with selective serotonin reuptake inhibitors (SSRIs) and/or clomipramine and cognitive behavioral therapy (CBT). However, nearly half of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f033a8a50921baae1b415124da2f024c
https://doi.org/10.1089/cap.2014.0128
https://doi.org/10.1089/cap.2014.0128
Amaç: Yaygın Gelişimsel Bozukluklar (YGB) ve eşlik eden Dikkat Eksikliği Hiperaktivite Bozukluğu (DEHB) belirtileri olan olgularda Metilfenidat (MPH) ilk tedavi seçeneği olmakla birlikte, sadece DEHB olan olgulara göre daha fazla yan etkiye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______9436::2b286cc1dd52ace451bb079ee68a735f
https://hdl.handle.net/11454/11955
https://hdl.handle.net/11454/11955
WOS: 000406733900004
PubMed ID: 29192941
Objective: Methylphenidate is the first-choice medication for the Pervasive Developmental Disorders (PDDs), and comorbid Attention Deficit Hyperactivity Disorder (ADHD). But this approach generally r
PubMed ID: 29192941
Objective: Methylphenidate is the first-choice medication for the Pervasive Developmental Disorders (PDDs), and comorbid Attention Deficit Hyperactivity Disorder (ADHD). But this approach generally r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e22327b6dc3b1bb4a206e41fd5f5cdc
https://hdl.handle.net/11454/32050
https://hdl.handle.net/11454/32050
Publikováno v:
Multiple Sclerosis and Related Disorders. 36:101394
Background Myelin Oligodendrocyte Glycoprotein (MOG) antibodies-related disease is mainly presented with acute disseminated encephalomyelitis (ADEM), recurrent optic neuritis, and neuromyelitis optica spectrum disorders (NMOSDs), however the complete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5b59449d24bef8b68ad22592ca55390
https://doi.org/10.1016/j.msard.2019.101394
https://doi.org/10.1016/j.msard.2019.101394
Publikováno v:
Journal of clinical psychopharmacology. 34(4)
The aims of this study were to evaluate the neuropsychological characteristics of the restrictive (R) subtype according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition and the attention-deficit/hyperactivity disorder (ADH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03d32d9de5af342868b2cb3500073076
https://pubmed.ncbi.nlm.nih.gov/24875071
https://pubmed.ncbi.nlm.nih.gov/24875071
Publikováno v:
Journal of attention disorders. 18(2)
Objective: The aim of this study was to compare the effect of methylphenidate (MPH) versus MPH + parent training in children with ADHD and oppositional defiant disorder/conduct disorder (ODD/CD) over a 12-month period. Method: After careful screening
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be94919fa81a70b3707020a9bb1f8b2b
https://pubmed.ncbi.nlm.nih.gov/22522574
https://pubmed.ncbi.nlm.nih.gov/22522574